Next Article in Journal
Automatic Defect Detection for TFT-LCD Array Process Using Quasiconformal Kernel Support Vector Data Description
Next Article in Special Issue
Identification of a Protein with Antioxidant Activity that is Important for the Protection against Beer Ageing
Previous Article in Journal
Ultrasmall Peptides Self-Assemble into Diverse Nanostructures: Morphological Evaluation and Potential Implications
Previous Article in Special Issue
Synthesis of Xylooligosaccharides of Daidzein and Their Anti-Oxidant and Anti-Allergic Activities
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 12
Issue 9
10.3390/ijms12095747
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Antioxidant Activity of New Coumarin Derivatives

by
Abdul Amir H. Kadhum
1,
Ahmed A. Al-Amiery
1,2,*,
Ahmed Y. Musa
1 and
Abu Bakar Mohamad
1
1
Department of Chemical and Process Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia, Bangi, Selangor 43600, Malaysia
2
Biotechnology Division, Applied Science Department, University of Technology, Baghdad 10066, Iraq
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2011, 12(9), 5747-5761; https://doi.org/10.3390/ijms12095747
Submission received: 12 July 2011 / Revised: 18 August 2011 / Accepted: 22 August 2011 / Published: 7 September 2011
(This article belongs to the Special Issue Antioxidants)
Browse Figures
Versions Notes

Abstract

:
The antioxidant activity of two synthesized coumarins namely, N-(4,7-dioxo-2- phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2-(2-oxo-2H-chromen-4-yloxy)acetamide 5 and N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2H-chromen-4-yloxy)acetamide 6 were studied with the DPPH, hydrogen peroxide and nitric oxide radical methods and compared with the known antioxidant ascorbic acid. Compounds 5 and 6 were synthesized in a good yield from the addition reaction of maleic anhydride or mercaptoacetic acid to compound 4, namely N′-benzylidene-2-(2-oxo-2H-chromen-4-yloxy)acetohydrazide. Compound 4 was synthesized by the condensation of compound 3, namely 2-(2-oxo-2H-chromen-4-yloxy) acetohydrazide, with benzaldehyde. Compound 3, however, was synthesized from the addition of hydrazine to compound 2, namely ethyl 2-(2-oxo-2H-chromen-4-yloxy)acetate, which was synthesized from the reaction of ethyl bromoacetate with 4-hydroxycoumarin 1. Structures for the synthesized coumarins 2–6 are proposed on the basis of spectroscopic evidence.

1. Introduction

Coumarin and its derivatives represent one of the most active classes of compound possessing a wide spectrum of biological activity [1–4]. Many of these compounds have proven to be active as antibacterial [5–7], antifungal [8], anti-inflammatory [9], anticoagulant [10], anti-HIV [11] and antitumor agents [12]. Coumarins are widely used as additives in food, perfumes, cosmetics [13], pharmaceuticals and optical brighteners [14] and would dispersed fluorescent and laser dyes [15]. Coumarins also have the super thermal stability and outstanding optical properties including extended spectral response, high quantum yields and superior photo stability. Optical applications of these compounds, such as laser dyes, nonlinear optical chromophores, fluorescent whiteners, fluorescent probes, polymer science, optical recording and solar energy collectors have been widely investigated [16–20]. Classical routes to coumarins incorporate Pechmann, Knoevenagel, Perkin, Reformatsky, and Wittig condensation reactions [21–24]. To make these classical reactions efficacious, several variations in terms of catalyst and reaction conditions have been introduced [25,26]. 4-Hydroxycoumarin and its derivatives have been effectively used as anticoagulants for the treatment of disorders in which there is excessive or undesirable cloterting, such as thrombophlebitis [27], pulmonary embolism [28], and certain cardiac conditions [29]. Several comparative pharmacological investigations of the 4-hydroxycoumarin derivatives have shown it to have good anticoagulant activity combined with low side effects and little toxicity [30]. Antioxidants possess the ability to protect the cellular organelles from damage caused by free radicals induced oxidative stress. Free radicals used include hydroxyl radical, superoxide anion radical and hydrogen peroxide. Highly reactive free radicals which are formed by exogenous chemicals, stress or in the food system are capable of oxidizing biomolecules, resulting in cancer, coronary heart disease and hypertension [31]. Generally, most of the free radicals generated from metabolism are scavenged by endogenous defense system such as catalase, superoxide dismutase and peroxidase–glutathione system [32].
The preparation of ethyl 2-(2-oxo-2H-chromen-4-yloxy)acetate 2, which was used as a starting material for the synthesis of compounds 5 and 6, is presented in this study. The chemical structures of the synthesized compounds 2–6 were conducted and confirmed. The in vitro antioxidant activities were investigated for the synthesized compounds 5 and 6.

2. Results and Discussion

2.1. Chemistry

The reaction sequence for the synthesis of N-(4,7-dioxo-2-phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2- (2-oxo-2H-chromen-4-yloxy)acetamide 5 and N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2Hchromen-4-yloxy)acetamide 6, is out lined in Scheme 1.
The synthesis of ethyl 2-(2-oxo-2H-chromen-4-yloxy)acetate 2 was conducted via reflux of Ethyl bromoacetate with 4-hydroxycoumarin 1 in the presence of anhydrous potassium carbonate in acetone. Hydrazinolysis of compound 2 with hydrazine hydrate produced hydrazide 3 in good yield. The FT-IR spectrum of compound 3 showed absorption bands in the 3297.3, 3211 cm−1 (hydrazide NH-NH2), 1711 cm−1 (lactonic -C=O carbonyl stretching), and 1671.2 cm−1 (amide -C=O carbonyl stretching). The 1H-NMR spectrum exhibited a singlet due to the -CO-NH-NH2 proton at δ 8.89 ppm. Compound 3 was thencondensed with benzaldehyde to make compound 4 that can be cyclized with maleic anhydride (or mercaptoacetic acid)to yield compounds 5 (and 6). The IR spectrum of compound 4 showed characteristic bands at 3191.1 cm−1 (NH), 1734.3 (C=O, lactone) cm−1, 1688 cm−1 (C=O, amide). The 1H-NMR spectrum showed the absence of NH2 protons, and the presence of the N=CH proton at 8.23 ppm. Compound 5 shows pronounced peaks; a singlet due to the NH proton at 9.58 in addition to a singlet for 1H assigned to the (-C=C-H). The IR spectrum of compound 6 showed characteristic bands at 3198.7 cm−1, 29211731 cm−1, and 1689 and 1667 cm−1 (NH), (C-H alkane), (C=O, lactone) and (C=O, amide) respectively. The 1H-NMR spectrum of compound 6 showed peaks at 5.87 ppm (s, 1H) =C-H and 3.91 (d, 2H, CH2).
The reaction of compound 4 with maleic anhydridecould be visualized through the mechanism shown in Scheme 2.

2.1.1. Computational Studies

An earlier study [33] has shown that atomic charges were affected by the presence of the substituent of rings. With the aid of a reference model, compound anoptimized geometry and the 3D geometrical structureis given in Figure 1 and Table 1, respectively. The data obtained show that the heat of formation are about 81.154956 kJ/mol) and the highest atomic charge in compound 5 is at [O(12) −0.510] followed by the next charge value at [O(10) −0.509] and [O(15) (−0.437)]. These data show clearly that these three atoms are the most reactive toward the addition, substitution reactions and bonding with the metal. The determined bond angle and twist angle, stretch (1.4560), bend (4.3225), stretch-bend (−0.1213). The 3D geometrical structure indicates that this molecule is a non-planarmolecular and the stereochemistry is [C(18): (S); C(19)–C(20): (E); C(7)–C(8): (Z)].

2.2. Pharmacology

2.2.1. Antioxidant Activity

Antioxidant compounds in food play an important role as a health-protecting factor. Scientific evidence suggests that antioxidants reduce the risk for chronic diseases including cancer and heart disease. Primary sources of naturally occurring antioxidants are whole grains, fruits and vegetables. Plant-sourced food antioxidants like vitamin C, vitamin E, carotenes, phenolic acids, phytate and phytoestrogens have been recognized as having the potential to reduce disease risk. Most of the antioxidant compounds in a typical diet are derived from plant sources and belong to various classes of compounds with a wide variety of physical and chemical properties. Some compounds, such as gallates, have strong antioxidant activity, while others, such as the mono-phenols are weak antioxidants [34]. The role of antioxidant is to remove free radicals. One important mechanism through which this is achieved is by donating hydrogen to free radicals in its reduction to non-reactive species. Addition of hydrogen would remove the odd electron feature which is responsible for radical reactivity. Free radicals have been a subject of significant interest among scientists in the past decade. Their broad range of effects in biological systems has drawn the attention of many workers. It has been proven that free radicals play an important role in the pathogenesis of certain diseases and aging. There are many reports that support the use of antioxidant supplementation in reducing the level of oxidative stress and in slowing or preventing the development of complications associated with diseases [35]. Many synthetic antioxidant components have shown toxic and/or mutagenic effects, and there-fore attention has been paid to naturally occurring antioxidants. Compound 5 and 6 were screened for in vitro antioxidant activity using (1,1-diphenyl-2-picrilhydrazyl) DPPH, Nitric oxide and hydrogen peroxide. They show good antioxidant activity against all methods (Figures 2–4). The hydrogen-donating activity, measured using DPPH radicals as hydrogen acceptor, showed that significant association could be found between the concentration of the novel molecule and the percentage of inhibition. Through DPPH test, compounds 5 and 6 have down to reduce the stable radical DPPH to the yellow-colored diphenylpicrylhydrazine. The method was based on the reduction of alcoholic DPPH solution in the presence of a hydrogen-donating antioxidant due to the formation of the non-radical form DPPH-H in the reaction [36]. The nitric oxide assay has been widely used to evaluate the effectiveness of the free radical scavenging on various antioxidant substances. Nitric oxide generated as a result of decomposition of sodium nitroprusside in aqueous medium interacts with oxygen at physiological pH to produce nitrite ions. The nitrite ions were subjected to diazotization followed by azo coupling reaction to yield an azo dye measured by an absorption band at 540 nm. The scavenging ability of the synthesized compounds 5 and 6 was compared with ascorbic acid as a standard. Nitric oxides radical inhibition study showed that the synthesized compounds were a potent scavenger of nitric oxide. The compounds 5 and 6 inhibited nitrite formation by competing with oxygen to react directly with nitric oxide and also to inhibit its synthesis. Scavengers of nitric oxide competed with oxygen, leading to the reduced production of nitric oxide [37].
There are two postulated mechanisms for the reaction of compound 5 as an antioxidant as shown in Schemes 3 and 4. The first mechanism depends on the benzyl hydrogen atom (bold hydrogen atom), where this atom was under the influence of two effects, namely resonance and inductive. The resonance effect of benzyl hydrogen makes the release of hydrogen as a free radical easy while the inductive effect on benzene ring, oxygen and nitrogen pushes the electrons toward a carbon free radical, resulting in the molecule becoming stable.
The second postulated mechanism fellows the route of the keto-enol forms as shown in Scheme 4.
For compound 6, the two suggested mechanisms depend on the keto-enol form as depicted on Schemes 5 and 6.

3. Experimental Section

3.1. General

All chemicals used were of reagent grade (supplied by either Merck or Fluka) and used as supplied without further purifications. The FTIR spectra were recorded as KBr disc on FTIR 8300 Shimadzu Spectrophotometer. The UV-Visible spectra were measured using Shimadzu UV-VIS. 160A spectrophotometer. Proton NMR spectra were recorded on Bruker - DPX 300 MHz spectrometer with TMS as the internal standard. Elemental micro analysis was carried out using a CHN elemental analyzer model 5500-Carlo Erba instrument.

3.2. Chemistry

3.2.1. Synthesis of Ethyl 2-(2-oxo-2H-chromen-4-yloxy)acetate 2

A suspension of 4-hydroxycoumarins 1 (6.17 mmol) in acetone (30 mL) was refluxed with ethyl bromoacetate (9.15 mmol) and K2CO3 (4.69 g, 33.91 mmol) for 12 h. After cooling, the mixture was evaporated to dryness and the residue was partitioned between CHCl3 (50 mL) and water (50 mL). The organic phase was dried (Na2SO4), filtered and evaporated to dryness. The residue was recrystallized from acetone; yield 92%; m.p. 99.0 °C; 1H-NMR (CDCl3): δ 3.22 (t, 3H, CH3), δ 3.85 (m, 2H, CH2), δ 4.91 (s, 2H) and δ 5.20, δ 5.250, δ 5.272 (s, 2H) for CH2), δ 5.78 (s, 1H) for -C=C-H), δ 7.291, δ 7.478, δ 7.80 (s, 1H) for aromatic ring); 13C-NMR: 167.2; 165.1; 163.4, 155.9; 134.2; 121.8; 121.1; 119.0; 113.8; 100.9; 65.3; 54.7; 22.12; IR: 2987.3 cm−1 (C-H, Aliphatic), 3089.5 cm−1 (C-H, Aromatic), 1759.3 cm−1 (C=O, Lactonic), 1717.6 cm−1 (C=O, Estric), 1629.2 cm−1 (C=C, Alkene), 1577.6 cm−1 (C=C, Aromatic); Theoretical Calculation for C13H12O5: C 62.90%, H 4.87%. Experimental: C 61.91% H 3.99%.

3.2.2. Synthesis of 2-(2-oxo-2H-chromen-4-yloxy)acetohydrazide 3

A solution of compound 2 (10 mmol) in ethanol 25 mL was refluxed with hydrazine hydrate (15 mmol) for 4 h. After concentrating the reaction mixture a solid mass separated out and recrystallized using ethanol, yield 51%, m.p. 228 °C; 1H-NMR (CDCl3): δ 4.48 (s, 2H, CH2), δ 4.65 (s, 2H, NH2), δ 8.89 (s, 1H, NH), δ 4.92 (s, 2H) and δ 5.210 (s, 2H) for (O-CH2), δ 5.72 (s, 1H) for (-C=C-H), δ 7.410, δ 7.521, δ 8.10 (s, 1H) for aromatic ring; IR: 3297.3, 3211 cm−1 (N-H), 2906.0 cm−1 (C-H, Aliphatic), 3072.7 cm−1 (C-H, Aromatic), 1711.5 cm−1 (C=O, Lacton), 1671.2 cm−1 (C=O, Amide); Theoretical Calculation for C11H10N2O4: C 56.41%, H 4.30%, N 11.96%. Experimental: C 57.13% H 4.01%, N 10.52%.

3.2.3. Synthesis of N′-benzylidene-2-(2-oxo-2H-chromen-4-yloxy)acetohydrazide 4

A solution of the compound 3 (0.2 mmol) in ethanol 25 mL was refluxed with benzaldehyde (0.2 mmol) for 20 h. After cooling to room temperature, a solid mass separated and recrystallized. Recrystallized from ethanol;yield 57%; m.p. 258 °C; 1H-NMR (CDCl3): δ 8.23, (s, 1H,N=CH), δ 8.11 (s, 1H, NH), δ 4.91 (s, 2H) and δ 5.340 (s, 2H) for O-CH2), δ 5.67 (s, 1H) for (-C=C-H), δ 7.240, δ 7.312, δ 7.97 (s, 1H) for aromatic ring; 13C-NMR (DMSO-d6): 170.0, 169.2, 164.1, 155.1,145.6, 136.9,129,8, 128, 125, 120.6, 119.9, 118.4,118.3, 117.9, 80.1, 65.2; IR: 3191.1cm−1 (N-H), 2901.0 cm−1 (C-H, Aliphatic), 3058.2 cm−1 (C-H, Aromatic), 1743.3 cm−1 (C=O, Lacton), 1688 cm−1 (C=O, Amide), 1613 cm−1 (C=N), 1627.7 cm−1 (C=C); Theoretical Calculation for C18H14N2O4: C 67.07%, H 4.38%, N 8.69%. Experimental: C 66.39% H 3.95%, N 7.97%.

3.2.4. Synthesis of N-(4,7-dioxo-2-phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2-(2-oxo-2H-chromen-4-yloxy) acetamide 5

Mixture of 1 mmole of compound 4 with 1 mmole of maleic anhydride in 50 mL of dry benzene was refluxed in water bath for 20 h. The solvent was removed and the precipitate was recrystallized from tetrahydrofuran; yield 44%; m.p. 201 °C; 1H-NMR (CDCl3): δ 3.93 and 4.22 (dd, 2H, CH2), δ 9.58 (s, 1H, NH), δ 4.81 (s, 2H) and δ 5.350 (s, 2H) for O-CH2), δ 6.11 (s, 1H) for (-C=C-H), δ 7.320, δ 7.412, δ 7.79 (s, 1H) for aromatic ring; 13C-NMR (DMSO-d6): 170.4, 167.2, 165.8, 160.6, 155.1, 155.4, 139.4, 136, 128.8, 125.8, 124.3, 120.6, 119.6, 117.1, 116.3 115.3, 113,100.6, 69.9, 55.4; IR: 3232.1cm−1 (N-H), 2979.5 cm−1 (C-H, Aliphatic), 3097.3 cm−1 (C-H, Aromatic), 1765, 1741 cm−1 (C=O), 1671 cm−1 (C=O, amide), 1617.8 cm−1 (C=N), 1632.6 cm−1 (C=C, Aromatic); Theoretical Calculation for C22H16N2O7: C 62.86%, H 3.84%, N 6.66%. Experimental: C 61.99% H 3.72%, N 5.90%.

3.2.5. Synthesis of N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2H-chromen-4-yloxy)acetamide 6

Mixture of 0.01 mole of Schiff base with 0.01 of mercaptoacetic acid in 50 mL of dry benzene was refluxed in water bath for 20 hours., filtered off, washed with water, dried and recrystallized from dichloromethane; yield 70%; m.p. 261 °C; 1H-NMR (CDCl3): δ 3.83 (, 2H, CH2), δ 5.40 (s, S-CH), δ 8.98 (s, 1H, NH), δ 4.77 (s, 2H) and δ 5.110 (s, 2H) for O-CH2), δ 5.82 (s, 1H) for (−C=C-H), δ 7.320, δ 7.441, δ 7.92 (s, 1H) for aromatic ring; 13C-NMR (DMSO-d6): 171, 169.0, 167.8, 154.1, 159.8, 128.2, 127.8, 126.1, 124.3, 120.1, 117.1, 114.4, 112.9,110.1 101.4, 77.6, 65.4, 33.2; IR: 3198.7cm−1 (N-H), 2921 cm−1 (C-H, Aliphatic), 3087.7 cm−1 (C-H, Aromatic), 1731 cm−1 (C=O, Lacton), 1689, 1667 cm−1 (C=O, amide), 1622 cm−1 (C=N), 1632.8 cm−1 (C=C, Aromatic); Theoretical Calculation for C20H16N2O5S: C 60.60%, H 4.07%, N 7.07%. Experimental: C 60.41% H 3.91%, N 6.88%.

3.3. Pharmacology

3.3.1. (2,2-diphenyl-1-picrylhydrazyl) (DPPH) Radical Scavenging Activity

The DPPH radical scavenging activities of the test samples compounds (5 and 6) were evaluated according to Soares, et al [38]. Initially, 0.1 mL of the samples at concentration of 250, 500, 750 and 1000 μg/mL was mixed with 1 mL of 0.2 mM DPPH that was dissolved in methanol. The reaction mixture was incubated in the dark for 20 min at 28 °C. The control contained all reagents without the sample while methanol was used as blank. The DPPH radical scavenging activity was determined by measuring the absorbance at 517 nm using the UV-VIS spectrophotometer. The DPPH radical scavenging activity of ascorbic acid was also assayed for comparison.
The percentage of DPPH radical scavenger was calculated using Equation 1.
S c a n v e n g i n g   e f f e c t ( % ) = A 0 - A 1 A 0 × 100
where A0 is the absorbance of the control reaction and A1 is the absorbance in the presence of the samples or standards.

3.3.2. Nitric Oxide Scavenging Activity

Sodium nitroprusside in aqueous solution at physiological pH generates nitric oxide spontaneously; it interacts with oxygen to produce nitrite ions, which can be estimated by the use of GriessIllosvoy reaction [39]. In the present investigation, GriessIllosvoy reagent was modified using naphthylethylenediaminedihydrochloride (0.1% w/v) instead of 1-naphthylamine (5%). The reaction mixture (3 mL) containing sodium nitroprusside (10 mM, 2 mL), phosphate buffer saline (0.5 mL) and compounds 5 and 6 (250, 500, 750 and 1000 μg/mL) or standard solution (0.5 mL) was incubated at 25 °C for 150 min. After the incubation, 0.5 mL of the reaction mixture containing nitrite was pipetted and mixed with 1 mL of sulphanilic acid reagent (0.33% in 20% glacial acetic acid) and allowed to stand for 5 min for completing diazotization. Then, 1 mL of naphthylethylenediaminedihydrochloride (1%) was added, mixed and allowed to stand for 30 min. A pink-colored chromophore was formed in diffused light. The absorbance of these solutions was measured at 540 nm against the corresponding blank. Ascorbic acid was used as standard. Nitric oxide percentage scavenging activity was then calculated using Equation 1.

3.3.3. Hydrogen Peroxide Scavenging Activity

A solution of hydrogen peroxide (40 mM) was prepared in phosphate buffer (pH 7.4). Different concentrations ((250, 500, 750 and 1000 μg/mL)) of synthesized compounds (or ascorbic acid) were added to a hydrogen peroxide solution (0.6 mL, 40 mM). Absorbance of hydrogen peroxide at 230 nm was determined after 10 min. against a blank solution containing phosphate buffer without hydrogen peroxide [40,41]. Hydrogen peroxide percentage scavenging activity was then calculated using Equation 1.

3.4. DFT

The molecular sketch of the reference compound was plotted using Visualization Materials Studio 5.5 software. All quantum chemical calculations were performed using the Density Functional Theory (DFT) in the methodology. DMol3 model was employed to obtain quantum chemical parameters and optimization of the molecule geometry. Molecular atomic charges were calculated by Mulliken population analysis.

4. Conclusions

In this study, the two coumarins, namely N-(4,7-dioxo-2-phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2- (2-oxo-2H-chromen-4-yloxy)acetamide and N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2H-chromen-4-yloxy)acetamide, have been successively synthesized, and characterized by using various spectroscopic methods and elemental analysis techniques. Two postulated mechanisms have been proposed for the action of compound as antioxidant. The antioxidant activity of the compounds was initially tested and showed that the compounds have improved properties compared to ascorbic acid.

References

  1. El-Agrody, A; Abd El-Latif1, M; El-Hady, N; Fakery1, A; Bedair, A. Hetero aromatization with 4-ydroxycoumarin Part II: Synthesis of some new pyrano[2,3-d]pyrimidines, [1,2,4]triazolo [1,5-c]pyrimidines and Pyrimido[1,6-b] [1,2,4]triazine derivatives. Molecules 2001, 6, 519–527. [Google Scholar]
  2. Rositca, DN; Vayssilov, GN; Rodios, N; Bojilova, A. Regio- and Stereoselective [2 + 2] Photodimerization of 3-Substituted 2-Alkoxy-2-oxo-2H-1,2-benzoxaphosphorines. Molecules 2002, 7, 420–432. [Google Scholar]
  3. Flašík, R; Stankovičová, H; Gáplovský, A; Donovalová, J. Synthesis and study of novel coumarin derivatives potentially utilizable as memory media. Molecules 2009, 14, 4838–4848. [Google Scholar]
  4. Kovalenko, S; Bylov, I; Sytnik, K; Chernykh, V; Bilokin, Y. A new pathway to 3-hetaryl-2-oxo- 2H-chromenes: On the proposed mechanisms for the reaction of 3-carbamoyl-2-iminochromenes with dinucleophiles. Molecules 2000, 5, 1146–1165. [Google Scholar]
  5. El-Saghier, A; Khodairy, A; Khodiyar, A. New synthetic approaches to condensed and spiro coumarins: Coumarin-3-thiocarboxamide as building block for the the synthesis of condense and spiro coumarins. Phosphorus Sulfur Silicon 2000, 160, 105–119. [Google Scholar]
  6. Al-Amiery, AA; Al-Bayati, R; Saour, K; Radi, M. Cytotoxicity, Antioxidant and Antimicrobial activities of novel 2-quinolone derivatives derived from coumarins. Research on Chemical Intermediates 2011. In press. [Google Scholar]
  7. Azizian, J; Mohammadi, A; Bidar, I; Mirazaei, P. KAl(SO4)2·12H2O (alum) a reusable catalyst for the synthesis of some 4-substituted coumarins via Pechmann reaction under solvent-free conditions. Montash Chem 2008, 139, 805–808. [Google Scholar]
  8. Satyanarayan, VS; Sreevani, P; Sivakumar, A. Synthesis and antimicrobial activity of new Schiff bases containing coumarin moiety and their spectral characterization. Arkivoc 2008, 17, 221–233. [Google Scholar]
  9. Garazd, MM; Muzychka, OV; Voyk, AI; Nagorichna, IV; Ogorodniichuk, AS. Modified coumarins. 27. Synthesis and antioxidant activity of 3-substituted 5,7-dihydroxy-4-methylcoumarins. Chem Nat Compd 2007, 43, 19–23. [Google Scholar]
  10. Smitha, G; Sanjeeva, R. ZrCl4-catalyzed Pechmann reaction: Synthesis of coumarins under solvent-free conditions. Synth Commun 2004, 34, 3997–4003. [Google Scholar]
  11. Kotali, A; Lafazanis, I; Harris, P. Synthesis of 6,7-diacylcoumarins via the transformation of a hydroxy into a carbonyl group. Synth Commun 2008, 38, 3996–4006. [Google Scholar]
  12. Nofal, ZM; El-Zahar, M; Abd El-Karim, S. Novel coumarin derivatives with expectedbiological activity. Molecules 2000, 5, 99–113. [Google Scholar]
  13. Kennedy, RO; Thornes, RD. Coumarins: Biology, Applications and Mode of Action; John Wiley and Sons: Chichester, England, 1997. [Google Scholar]
  14. Zabradnik, M. The Production and Application of Fluorescent Brightening Agents; John Wiley and Sons: New York, NY, USA, 1992. [Google Scholar]
  15. Heravi, M; Sadjadi, S; Oskooie, H; Shoar, R; Bamoharram, F. The synthesis of coumarin-3-carboxylic acids and 3-acetyl-coumarin derivatives using heteropolyacids as heterogeneous and recyclable catalysts. Catal Commun 2008, 9, 470–474. [Google Scholar]
  16. Lin, S; Kuo, P; Yang, D. Design and synthesis of a coumarin-based acidichromic colorant. Molecules 2007, 12, 1316–1324. [Google Scholar]
  17. Ray, D; Bharadwaj, PK. A Coumarin-derived fluorescence probe selective for magnesium. Inorg Chem 2008, 47, 2252–2254. [Google Scholar]
  18. Al-Amiery, AA; Musa, AY; Kadhum, AH; Mohamad, A. The use of umbelliferone in the synthesis of new heterocyclic compounds. Molecules 2011, 16, 6833–6843. [Google Scholar]
  19. Hung, TT; Lu, YJ; Liao, WY; Huang, CL. Blue violet laser write-once optical disk with coumarin derivative recording layer. IEEE Trans Magn 2007, 43, 867–869. [Google Scholar]
  20. Hara, K; Sayama, K; Ohga, Y; Shinpo, A; Suga, S; Arakawa, H. A coumarin-derivative dye sensitized nanocrystalline TiO2 solar cell having a high solar-energy conversion efficiency up to 5.6%. Chem Commun 2001, 569–571. [Google Scholar]
  21. Mukhatar, S; Mujeebur, RVP; Ansari, WH; Lemiere, G; de Groot, A; Dommisse, R. Bifunctional derivative of p,p′-dichlorochalcone. Part II. Synthesis of a novel compound 2-[2-Carboxymethylthio-2-(4-chlorophenyl)ethyl]-2-(4-chlorophenyl)-4-thiazolidinone. Molecules 1999, 4, 232–237. [Google Scholar]
  22. Milan, C; Maja, M; Tomislav, B; Nela, D; Valentina, R. Design and synthesis of some thiazolidin-4-ones based on(7-hydroxy-2-oxo-2h-chromen-4-yl) acetic acid. Molecules 2009, 14, 2501–2513. [Google Scholar]
  23. Rajithaa, B; Kumara, VN; Someshwara, P; Madhava, JV; Reddy, PN; Reddy, YH. Dipyridine copper chloride catalyzed coumarin synthesis via Pechmann condensation under conventional heating and microwave irradiation. Arkivoc 2006, xii, 23–27. [Google Scholar]
  24. Murraya, R; Jorge, Z. A simple method for differentiating between angular and linear 5-methoxyfuranocoumarins. Phytochemistry 1984, 23, 697–699. [Google Scholar]
  25. Chavan, S; Shivasankara, K; Sivappaa, R; Kalea, R. Zinc mediated transesterification of β-ketoesters and coumarin synthesis. Tetrahedron Lett 2002, 43, 8583–8586. [Google Scholar]
  26. Yavari, I; Hekmat-Shoar, R; Zonouzi, A. A new and efficient route to 4-carboxymethylcoumarins mediated by vinyltriphenylphosphonium salt. Tetrahedron Lett 1998, 39, 2391–2392. [Google Scholar]
  27. Dittmer, DC; Li, Q; Avilov, DV. Synthesis of coumarins, 4-hydroxycoumarins, and 4-hydroxyquinolinones by tellurium-triggered cyclizations. J Org Chem 2005, 70, 4682–4686. [Google Scholar]
  28. Verdía, P; Santamarta, F; Tojo, E. Knoevenagel reaction in [MMIm][MSO4]: Synthesis of coumarins. Molecules 2011, 16, 4379–4388. [Google Scholar]
  29. Shapiro, S; Sherwin, B. Thromboembolization. II. The use of dicumarol (3,3′-methylenebis (4-hydroxycoumarin) in embolization. Report of five cases. N Y State J Med 1943, 43, 45–52. [Google Scholar]
  30. Butsch, WL; Stewart, JD. Administration of dicoumarin compound for prophylaxis of postoperative thrombosis and embolism. Arch Surg 1942, 45, 551–553. [Google Scholar]
  31. Arti, RV; Vijayakumar, M; Chandana, VR; Chandra, SM. In vitro and in vivo antioxidant properties and DNA damage protective activity of green fruit of Ficusglomerata. Food Chem Toxicol 2010, 48, 704–709. [Google Scholar]
  32. Aruoma, OI; Cuppett, SL. Antioxidant Methodology: In Vivo and In Vitro Concepts; AOCS Press: Champaign, IL, USA, 1997; pp. 141–172. [Google Scholar]
  33. Al-Amiery, AA; Al-Majedy, K; Abdulreazak, H; Abood, H. Synthesis, characterization, theoretical crystal structure and antibacterial activities of some transition metal complexes of the thiosemicarbazone (Z)-2-(pyrrolidin-2-ylidene)hydrazinecarbothioamide. Bioinorg Chem Appl 2011, 2011. [Google Scholar] [CrossRef]
  34. Kadhum, AH; Mohamad, A; Al-Amiery, AA. Antimicrobial and anti-oxidant activities of new metal complexes derived from 3-aminocoumarin. Molecules 2011, 16, 6969–6984. [Google Scholar]
  35. Rose, WM; Creighton, MO; Stewart, DHPJ; Sanwal, M; Trevithick, GR. In vivo effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophtalmol 1972, 17, 61–66. [Google Scholar]
  36. Williams, W; Cuvelier, M; Berset, C. Use of a free radical method to evaluate antioxidant activity. Lebensm Wiss Technol 1995, 28, 25–30. [Google Scholar]
  37. Marcocci, L; Packer, L; Droy-Lefai, MT; Sekaki, A; Albert, M. Antioxidant action of Ginkgo biloba extracts EGb 761. Methods Enzymol 1994, 234, 462–475. [Google Scholar]
  38. Soares, JR; Dinis, TCP; Cunha, AP; Almeida, LM. Antioxidant activities of some extracts of thymus zygis. Free Radic Res 1997, 26, 469–478. [Google Scholar]
  39. Garratt, DC. The Quantitative Analysis of Drugs; Chapman and Hall Ltd: Tokyo, Japan, 1964; Volume 3, pp. 456–458. [Google Scholar]
  40. Duh, PD; Tu, YY; Yen, GC. Antioxidant activity of water extract of Harng Jyur (Chyrsanthemum morifolium Ramat). Lebn Wissen Technol 1999, 32, 269. [Google Scholar]
  41. Chen, Y; Wong, M; Rosen, R; Ho, C. 2,2-Diphenyl-1-picrylhydrazyl radical scavenging active components from Polygonum multiflorum thunb. J Agric Food Chem 1999, 47, 2226–2228. [Google Scholar]
Ijms 12 05747f1 1024
Figure 1. Optimized 3D geometrical structure for compound 5.
Figure 1. Optimized 3D geometrical structure for compound 5.
Ijms 12 05747f1
Ijms 12 05747f2 1024
Figure 2. Effect of compound 5 and 6 toward 1,1-diphenyl-2-picrilhydrazyl (DPPH).
Figure 2. Effect of compound 5 and 6 toward 1,1-diphenyl-2-picrilhydrazyl (DPPH).
Ijms 12 05747f2
Ijms 12 05747f3 1024
Figure 3. Effect of compound 5 and 6 toward nitric oxide.
Figure 3. Effect of compound 5 and 6 toward nitric oxide.
Ijms 12 05747f3
Ijms 12 05747f4 1024
Figure 4. Effect of compound 5 and 6 toward hydrogen peroxide.
Figure 4. Effect of compound 5 and 6 toward hydrogen peroxide.
Ijms 12 05747f4
Ijms 12 05747f5 1024
Scheme 1. Reaction sequences of compounds 5 and 6.
Scheme 1. Reaction sequences of compounds 5 and 6.
Ijms 12 05747f5
Ijms 12 05747f6 1024
Scheme 2. Mechanism of formation of compound 5.
Scheme 2. Mechanism of formation of compound 5.
Ijms 12 05747f6
Ijms 12 05747f7 1024
Scheme 3. Suggested mechanism for compound 5 as antioxidant.
Scheme 3. Suggested mechanism for compound 5 as antioxidant.
Ijms 12 05747f7
Ijms 12 05747f8 1024
Scheme 4. Suggested mechanism for compound 5 fellow the route of the keto-enol forms.
Scheme 4. Suggested mechanism for compound 5 fellow the route of the keto-enol forms.
Ijms 12 05747f8
Ijms 12 05747f9 1024
Scheme 5. Suggested mechanism for compound 6 fellow the route of the keto-enol forms.
Scheme 5. Suggested mechanism for compound 6 fellow the route of the keto-enol forms.
Ijms 12 05747f9
Ijms 12 05747f10 1024
Scheme 6. Suggested mechanism for compound 6 fellow the route of the keto-enol forms
Scheme 6. Suggested mechanism for compound 6 fellow the route of the keto-enol forms
Ijms 12 05747f10
Table
Table 1. Atomic charge (Mulliken atomic charges) of synthesized compound 5.
Table 1. Atomic charge (Mulliken atomic charges) of synthesized compound 5.
AtomChargeAtomChargeAtomChargeAtomCharge
C (1)0.044C (13)−0.138C (25)0.110H (37)0.189
C (2)0.365C (140.549C (26)−0.203H (38)0.188
C (3)−0.196O (15)−0.437C (27)−0.112H (39)0.325
C (4)−0.111N (16)−0.400C (28)−0.117H (40)0.182
C (5)−0.125N (17)−0.264C (29)−0.112H (41)0.161
C (6)−0.180C (18)0.185C (30)−0.180H (42)0.165
C (7)413C (19)−0.160O (31)−0.465H (43)0.188
C (8)−0.339C (20)−0.159H (32)0.147H (44)0.126
C (9)0.556C (21)0.517H (33)0.130H (45)0.122
O (10)−0.509C (22)0.560H (34)0.126H (46)0.123
O (11)−0.426O (23)−0.499H (35)0.147H (47)0.152
O (12)−0.510O (24)−0.411H (36)0.183--

Share and Cite

MDPI and ACS Style

Kadhum, A.A.H.; Al-Amiery, A.A.; Musa, A.Y.; Mohamad, A.B. The Antioxidant Activity of New Coumarin Derivatives. Int. J. Mol. Sci. 2011, 12, 5747-5761. https://doi.org/10.3390/ijms12095747

AMA Style

Kadhum AAH, Al-Amiery AA, Musa AY, Mohamad AB. The Antioxidant Activity of New Coumarin Derivatives. International Journal of Molecular Sciences. 2011; 12(9):5747-5761. https://doi.org/10.3390/ijms12095747

Chicago/Turabian Style

Kadhum, Abdul Amir H., Ahmed A. Al-Amiery, Ahmed Y. Musa, and Abu Bakar Mohamad. 2011. "The Antioxidant Activity of New Coumarin Derivatives" International Journal of Molecular Sciences 12, no. 9: 5747-5761. https://doi.org/10.3390/ijms12095747

APA Style

Kadhum, A. A. H., Al-Amiery, A. A., Musa, A. Y., & Mohamad, A. B. (2011). The Antioxidant Activity of New Coumarin Derivatives. International Journal of Molecular Sciences, 12(9), 5747-5761. https://doi.org/10.3390/ijms12095747

Article Metrics

Back to TopTop